Related Experiment Video
Updated: Sep 4, 2025

05:58
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
1.3K
Microfluidic techniques for isolation, formation, and characterization of circulating tumor cells and clusters
Celine Macaraniag1, Qiyue Luan1, Jian Zhou1
1Department of Biomedical Engineering, University of Illinois Chicago, Chicago, Illinois 60607, USA.
APL Bioengineering
|July 20, 2022
Summary
Circulating tumor cell (CTC) clusters, unlike single CTCs, indicate poor prognosis and higher metastasis risk. Microfluidic systems are crucial for isolating and analyzing these rare CTC clusters for better cancer insights and therapies.
Area of Science:
- Oncology
- Biotechnology
- Microfluidics
Background:
- Circulating tumor cell (CTC) clusters are linked to poor prognosis, increased metastatic potential, and distinct molecular profiles compared to single CTCs.
- Studying CTC clusters offers insights into genetic, somatic, and epigenetic differences between circulating tumor cells and primary/metastatic sites.
Purpose of the Study:
- To review the advantages and challenges of microfluidic systems for the isolation, formation, and characterization of CTC clusters.
- To highlight the potential of microfluidics in advancing cancer research and developing personalized therapies.
Main Methods:
- Microfluidic systems enable efficient isolation of rare CTC clusters from whole blood via liquid biopsy.
- Microfluidics facilitates the development of in vitro models for CTC cluster characterization and analysis.
Main Results:
- Microfluidic platforms are essential for studying CTC clusters, providing insights into cancer biology and metastasis.
- These systems offer a means to analyze rare CTC clusters, which are associated with poor patient prognosis.
Conclusions:
- Microfluidics plays a vital role in the isolation, formation, and characterization of CTC clusters.
- Advancements in microfluidic platforms can enhance our understanding of cancer metastasis and lead to novel therapeutic strategies.

